Accelerating vaccine innovation: Exploring Croda’s breakthrough in Sustainable Squalene
Join a 30-minute webinar that transforms your understanding of today’s vaccine development. The webinar features presentations from Dennis Christensen, PhD – Head of R&D Adjuvant Systems, and Rebecca Wood - Life Sciences Sustainability Manager. The webinar will feature the science behind Croda Pharma’s latest innovation in Sustainable Squalene, an essential excipient in vaccine adjuvant systems. You will learn how this groundbreaking innovation not only reduces environmental impact but also helps deliver high-quality squalene for a range of vaccines that target diseases like influenza, tuberculosis, shingles, schistosomiasis, HIV, and more.
What you will learn:
- Why adjuvants matter: Explore how adjuvants enhance vaccine efficacy, with a special focus on squalene's established advantages.
- Sustainable solutions: Discover how Croda achieves secure and scalable supply chains through shark-free sourcing methods while minimising the product's carbon footprint.
- Quality & consistency: Stringent manufacturing processes combined with stability data provide essential assurance for both vaccine purity and reliability.
- Beyond influenza: Explore future clinical development pathways for the most critical disease areas.
This session has been designed for vaccine R&D professionals and manufacturers along with academic researchers. Secure your spot now to see how Croda Pharma’s Sustainable Squalene can accelerate the future of vaccine innovation.
Speakers
Dr. Christensen was appointed as Global Head of R&D for Adjuvant Systems at Croda Pharma after 18 years in adjuvant research at Statens Serum Institut, Denmark. During his career his research focus has been on pharmaceutical and immunological aspects of vaccine adjuvants and delivery systems. In this period, he has played a key role in the development of the CAF® adjuvant portfolio. His recent research includes designing vaccines that target specific subsets of APCs and direction of vaccine-induced immune responses to specific tissues. He is a key opinion leader in the vaccine adjuvant research field and has an extensive experience with international vaccine research collaborations and with coordinating the research work in such projects.
Title:Accelerating vaccine innovation: Exploring Croda’s breakthrough in Sustainable Squalene
Date:15/04/25, 10:00 CEST
Duration:30 minutes
Available On Demand